Equities

Deva Holding AS

DEVA.E:IST

Deva Holding AS

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (TRY)64.35
  • Today's Change0.55 / 0.86%
  • Shares traded692.39k
  • 1 Year change-23.39%
  • Beta0.9590
Data delayed at least 15 minutes, as of Sep 20 2024 16:09 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of TRY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments4,0972,2011,311
Total Receivables, Net4,1102,912973
Total Inventory4,7183,963976
Prepaid expenses31040886
Other current assets, total1419722
Total current assets13,2489,6813,368
Property, plant & equipment, net7,4646,0681,060
Goodwill, net25211.78
Intangibles, net4,2003,571354
Long term investments07120
Note receivable - long term------
Other long term assets------
Total assets25,82520,5365,080
LIABILITIES
Accounts payable1,0331,173351
Accrued expenses46728481
Notes payable/short-term debt5,4704,049785
Current portion long-term debt/capital leases402719329
Other current liabilities, total58742687
Total current liabilities7,9586,6511,632
Total long term debt439833620
Total debt6,3115,6001,734
Deferred income tax--1,104--
Minority interest------
Other liabilities, total417418100
Total liabilities8,8159,0062,352
SHAREHOLDERS EQUITY
Common stock200200200
Additional paid-in capital45392.87
Retained earnings (accumulated deficit)13,2858,4232,362
Treasury stock - common(0.03)(0.03)(0.03)
Unrealized gain (loss)------
Other equity, total3,4802,868163
Total equity17,01011,5302,728
Total liabilities & shareholders' equity25,82520,5365,080
Total common shares outstanding200200200
Treasury shares - common primary issue0.030.030.03
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.